Similar articles

• Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation.

  Hendry A, Campbell AM, Campbell G, Macdonald JB, Williams BO. Hendry A, et al. Scott Med J. 1994 Aug;39(4):110-1. doi: 10.1177/003693309403900404. Scott Med J. 1994. PMID: 8778957
• Preventing strokes in non-rheumatic atrial fibrillation.

  Baliga RR, Webster J. Baliga RR, et al. Br J Hosp Med. 1993 Oct 20-Nov 2;50(8):452-7. Br J Hosp Med. 1993. PMID: 8275283 Review.
• Antithrombotic therapy in atrial fibrillation.

  Connolly SJ, Turpie AG. Connolly SJ, et al. Can J Cardiol. 1996 Jan;12 Suppl A:17A-20A. Can J Cardiol. 1996. PMID: 8597996 Review. No abstract available.
• Antithrombotic therapy in stroke prevention.

  Tilney MK. Tilney MK. Br J Hosp Med. 1994 Sep 7-20;52(5):239. Br J Hosp Med. 1994. PMID: 7820324 No abstract available.
• Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme.

  Proietti M, Mairesse GH, Goethals P, Scavee C, Vijgen J, Blankoff I, Vandekerckhove Y, Lip GY; Belgian Heart Rhythm Week Investigators. Proietti M, et al. Eur J Prev Cardiol. 2017 Feb;24(3):328-334. doi: 10.1177/2047487316682349. Epub 2016 Dec 5. Eur J Prev Cardiol. 2017. PMID: 27909151